FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment ...

Public health officials across several states have issued water quality advisories and beach closures as the summer swimming ...

Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients ...

The powerful antimicrobial teixobactin was discovered using a new technique that could speed up the discovery of new antibiotics to tackle resistance ...

A section of the Canal Saint-Martin has been open for swimming, under regulated conditions, since June 16. But police and ...

First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...

The approval of Utebzi provides clinicians with the first oral carbapenem option to treat adult complicated urinary tract infections, potentially reducing the clinical and financial burdens of ...

UTIs are most often caused by certain bacteria getting into the urinary system. They can vary in severity and can be debilitating (especially if they're recurring). Pain or a burning feeling when you ...

First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to intravenous treatmentiMore than 3 million cases of cUTIs are trea ...

What Is Zaynich, and Why Does It Matter? Zaynich (cefepime and zidebactam) is an intravenous (IV) antibiotic that is FDA-approved for adults with complicated urinary tract infections (cUTIs) that are ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Denver developer is planning ...